Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis

More than 70% of patients with ovarian cancer are diagnosed in advanced stages. Therefore, it is urgent to identify a promising prognostic marker and understand the mechanism of ovarian cancer metastasis development. By using proteomics approaches, we found that UDP‐glucose dehydrogenase (UGDH) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Li‐Hsun, Chou, Hsiu‐Chuan, Chang, Shing‐Jyh, Liao, En‐Chi, Tsai, Yi‐Ting, Wei, Yu‐Shan, Chen, Hsin‐Yi, Lin, Meng‐Wei, Wang, Yi‐Shiuan, Chien, Yu‐An, Yu, Xin‐Ru, Chan, Hong‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578908/
https://www.ncbi.nlm.nih.gov/pubmed/32893977
http://dx.doi.org/10.1111/jcmm.15808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578908/
https://www.ncbi.nlm.nih.gov/pubmed/32893977
http://dx.doi.org/10.1111/jcmm.15808

Ejemplares similares